LDHA and lung adenocarcinoma: In highly glycolytic NSCLCs (accounting for >85% LCs) [67], LDHA overexpression is the key event for the enhancement of aerobic glycolysis, which promotes tumour malignant behaviour, and invasive ability through the activation of epithelial–mesenchymal transition in lung adenocarcinoma [68].